SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
281>> Note: According to Swedish news media the research was previously supposcaram(o)uche-10/4/2002
280Swede researchers apply for psoriasis gene patent Friday October 4, 11:03 am ET Icebrg-10/4/2002
279Lexicon; LG688 THE WOODLANDS, Texas, Oct. 4 /PRNewswire-FirstCall/ -- Lexicon Gnigel bates-10/4/2002
278[ anti-CD4/RA/Genmab ] >> Anti-CD4 as a therapeutic has been of interest scaram(o)uche-9/24/2002
277Am Coll Rheum abstracts available soon (eom)?keokalani'nui-9/23/2002
276They seem, to me, to be terribly sloppy when describing this antibody. What is scaram(o)uche-9/23/2002
275US FDA Approves Genmab's IND Humax-Cd4 to Treat Psoriasis Phase IIb Study InIcebrg-9/23/2002
274thanks! (eom)scaram(o)uche-9/17/2002
273"Did anyone else understand that the trial was going to be that large? Did aknahow-9/17/2002
272I don't get it. Genentech and XOMA provide conclusive data re. efficacy. Bscaram(o)uche-9/17/2002
271<i>...MEDI-507 was tested in a very small i.v. phase II trial. Mean PASI rnigel bates-9/13/2002
270my bias extends way back, back to......... J Immunol 1998 Apr 15;160(8):3797-80scaram(o)uche-9/13/2002
269Rick, <I>But, IMO, there's been little in the way of biological insigsoftware salesperson-9/13/2002
268fda.govscaram(o)uche-9/13/2002
267I'm certain that they will. I was just ticked at the spin. But.... FDA iscaram(o)uche-9/13/2002
266Rick, do you mean BGEN made a prior reply to the FDA's request for a completaknahow-9/13/2002
265>> on Track << I'd be ticked if I were a BGEN shareholder. Thescaram(o)uche-9/12/2002
264[ Biogen/LFA3tip (Amevive) status ] Biogen's AMEVIVE(R) (Alefacept) Applicascaram(o)uche-9/12/2002
263Did not meet the FDA's holy grail???? Alefacept, efalizumab Biologics Appeaaknahow-9/12/2002
262[ IDEC/anti-B7 crashes ] IDEC Pharmaceuticals Announces Results of Phase II Cliscaram(o)uche-9/5/2002
261D2E7 / JRA / Crohn's ABBOTT PARK, Ill., Sept. 4 /PRNewswire-FirstCall/ -- Anigel bates-9/4/2002
260Genmab / IL15 COPENHAGEN, Denmark, Sept. 4 /PRNewswire-FirstCall/ -- Genmab A/Snigel bates-9/4/2002
259Another on TNF inhibitors www2.eskinandallergynews.comaknahow-8/29/2002
258www2.eskinandallergynews.com 12 page pdf file on treatment of psoriasisaknahow-8/29/2002
257Eur J Pharmacol 2002 Jul 19;448(2-3):231-238 PPARgamma ligands inhibit nitrotyscaram(o)uche-8/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News